Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020

NCT04352751 is registered in ClinicalTrials.gov with Hilton Pharma as lead sponsor.

NCT NCT04352751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04352751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020
Lead sponsor
Hilton Pharma
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2020
Completion date
April 30, 2021
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19